(Q44059979)

29 November 2017

Local tumor irradiation augments the antitumor effect of cytokine-producing autologous cancer cell vaccines in a murine glioma model (English)

1 reference

29 November 2017

Katalin Lumniczky

1

1 reference

29 November 2017

Szilvia Desaknai

2

1 reference

29 November 2017

Laszlo Mangel

3

1 reference

29 November 2017

Bela Szende

4

1 reference

29 November 2017

Hirofumi Hamada

5

1 reference

29 November 2017

Egon J Hidvegi

6

1 reference

29 November 2017

Geza Safrany

7

1 reference

29 November 2017

1 January 2002

1 reference

29 November 2017

1 reference

29 November 2017

9

1 reference

29 November 2017

1

1 reference

29 November 2017

44-52

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700398

29 November 2017

0 references

cites work

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700398

Definition of a unique cell surface antigen of mouse leukemia RL male 1 by cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700398

Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700398

Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700398

Evaluation of combined vaccinia virus-mediated antitumor gene therapy with p53, IL-2, and IL-12 in a glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700398

Low-dose vaccinia virus-mediated cytokine gene therapy of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700398

The treatment of established intracranial tumors by in situ retroviral IFN-gamma transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700398

Immunological responsiveness to interleukin-2-producing brain tumors can be restored by concurrent subcutaneous transplantation of the same tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700398

Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700398

Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700398

Effect of in situ retroviral interleukin-4 transfer on established intracranial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700398

Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700398

IFN-beta gene therapy induces systemic antitumor immunity against malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700398

Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700398

Prolongation of survival of mice with glioma treated with semiallogeneic fibroblasts secreting interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700398

Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700398

Adenovirus mediated gene therapy in a glioblastoma vaccine model; specific antitumor immunity and abrogation of immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700398

Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700398

Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700398

Combined radiation and p53 gene therapy of malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700398

Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700398

National survey of patterns of care for brain-tumor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700398

inferred from DOI database lookup

7 January 2021

based on heuristic

Brain tumor treatment with IL-2 and IL-12 producing autologous cancer cell vaccines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700398

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CGT.7700398

1 reference

29 November 2017

1 reference